KOHN & SHAWN PHARMATECH BIOTECHNOLOGY

Kangyuxin Biotechnology Co., Ltd. was established in October 2013, specializing in the research and development, production, sales and related service technology development of pyrazine intermediates and process libraries. The core technology of pyrazine derivatives of Kangyuxin ranks the leading level in China, and the R&D varieties and market share of pyrazine series products rank the first in the subdivision field, and have been successfully approved as "Gansu Province Specialized and special small and medium-sized enterprises", "National high-tech enterprises" and "Gansu Province Enterprise Technology Center"... Kangyuxin has established long-term technical exchange relations with Lanzhou University, Northwest Normal University, Shanghai Organic Research Institute and other famous domestic universities and research institutes, with profound scientific research strength support, and hired a group of professors and industry experts as R & D guidance, to build a bridge between..

Also known as: Kohn & Shawn Pharmatech Biotechnology Co., LTD